research Recurrence of Pemphigus Vulgaris Associated With Interleukin 2 Therapy
This study describes a patient with metastatic renal cell carcinoma who experienced a recurrence of pemphigus vulgaris after receiving interleukin 2 immunotherapy, suggesting a possible link between the treatment and autoimmune disease recurrence.
